Results 221 to 230 of about 713,346 (360)

Microfluidic electro‐viscoelastic manipulation of extracellular vesicles

FEBS Open Bio, EarlyView.
The electro‐viscoelastic manipulation as a potential method for separation of particles based on size. The particles introduced as a sheath flow migrate to the channel center under the influence of simultaneously applied electric field and pressure driven flow.
Seyedamirhosein Abdorahimzadeh, Éva Bozó, Zikrullah Bölükkaya, Artem Zhyvolozhnyi, Anatoliy Samoylenko, Henrikki Liimatainen, Seppo J. Vainio, Caglar Elbuken   +7 more
wiley   +1 more source

IL-1 Receptor Antagonist Antibodies in Idiopathic Recurrent Pericarditis.

JAMA Netw Open
Wu MA, Kessel C, Fadle N, Regitz E, Fuehner S, Negro E, Berra S, Pfeifer J, Ceriani E, Thurner B, Klingel K, Caforio A, Imazio M, Brucato A, Thurner L.   +14 more
europepmc   +1 more source

Variant angina associated with a CGRP receptor antagonist: a case report. [PDF]

BMC Neurol
Jeon H, Cho JM.
europepmc   +1 more source

Pharmacological profile of MM-218, a novel 5-HT3 receptor antagonist.

, 1996
Hiroyuki Iizuka, Shuji Kojima, Atsushi Pukuzaki, Yoko Osaka, Shinji Tsuchiya   +4 more
openalex   +1 more source

Interplay between RNA‐protein interactions and RNA structures in gene regulation

FEBS Open Bio, EarlyView.
Methodological advances in mapping transcriptome‐wide RNA‐protein interactions and RNA structures have started to uncover the potential of RNP conformations in gene regulation. Competing RNA–RNA, RNA‐protein and protein–protein interactions shape the compaction and function of RNPs throughout their lifetime and may provide novel therapeutic targets in ...
Jenni Rapakko, Mauro Scaravilli, Minna‐Liisa Änkö   +2 more
wiley   +1 more source

Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study. [PDF]

J Clin Med
Arai T, Hirose M, Kagawa T, Takeuchi N, Kobayashi T, Inoue Y, Matsuda Y.   +6 more
europepmc   +1 more source

In vitro pharmacology of U-97018, a novel AT1 subtype angiotensin II receptor antagonist.

, 1994
Osamu Morita, Yuko Harasawa, Kazunori Ozawa, Hiroshi Kushida, Mineo Kunihara   +4 more
openalex   +1 more source

Lactoferrin treatment activates acetylcholinesterase, decreasing acetylcholine levels in non‐small cell lung cancer (NSCLC) cell culture supernatants, inhibiting cell survival

FEBS Open Bio, EarlyView.
Representation of the suggested mode of action of lactoferrin (Lf) in nonsmall cell lung cancer (NSCLC) A549 cells. Lf induces activation of caspase‐3 by activating p53 and AChE leading to decreased ACh concentrations. In turn, ACh signaling leads to activation of VEGF and AKT and blocking of caspase‐3.
Stuti Goel, Caroline Wozniak, Aya Sabri, Ben Haddad, Brooke Lopo, Alvaro Cobos, Sarah Sarofim, Jeffrey Guthrie, Deborah Heyl, Hedeel Guy Evans   +9 more
wiley   +1 more source

P2X4 Receptor Antagonist Ameliorates Ocular Pain in Rats After Lacrimal Gland Removal. [PDF]

Transl Vis Sci Technol
Chen M, Bäurle S, Karlstetter M, Simmons X, Seo S, Yiu SC.   +5 more
europepmc   +1 more source

Serum interleukin-1 receptor antagonist levels are a useful marker of disease activity and risk of relapse in large vessel vasculitis.

Koji Suzuki, Sho Ishigaki, Mitsuhiro Akiyama, Keiko Yoshimoto, Waleed Alshehri, Kanako Shimanuki, Koichi Saito, Hiroshi Takei, Noriyasu Seki, Hideto Tsujimoto, Kenji Chiba, Yuko Kaneko   +11 more
openalex   +1 more source